Walnut Consumption May Improve Cardiovascular Disease Risk

20 de October de 2021
Many studies have looked at the beneficial effects of nut consumption and how it relates to various health outcomes, especially cardiovascular disease. A new study, published in Circulation goes further, running a randomized controlled trial of 2 years and specifically looking at elderly individuals and walnut consumption.
 
For the trial, named The Walnuts and Healthy Aging (WAHA), researchers analyzed healthy elders ranging in age from 63-79. The study had two centers, one in Barcelona, Spain, and another in California, USA. It lasted a total of 2 years and included 2 monthly visits to measure compliance, tolerance, medication changes, and body weight. In total, 708 participants started the trial and were randomized into a walnut-free, control group, or a walnut-supplemented diet. Those receiving walnuts were instructed to consume around 15% of their daily energy in walnuts, between 30-60 g/day.
 
636 participants completed the study for a retention rate of 90%, while 628 had full data for lipoprotein analysis. It was found that the walnut diet significantly decreased total cholesterol, LDL (“bad”) cholesterol, and intermediate-density lipoprotein. Researchers pointed out that the results did not differ by the location of the study, however, lipid response did differ by sex: LDL cholesterol was reduced by 7.9% in men and by 2.6% in women. The results support the notion that adding walnuts (around 15% of energy) to the daily diet of healthy elders may be useful to lower atherogenic lipids and improve cardiovascular disease risk.
 
This research was supported by a grant from the California Walnut Commission.

Rajaram, S., Cofán, M., Sala-Vila, A., Haddad, E., Serra-Mir, M., Bitok, E., … & Ros, E. (2021). Effects of Walnut Consumption for 2 Years on Lipoprotein Subclasses Among Healthy Elders: Findings From the WAHA Randomized Controlled Trial. Circulation.

Latest News

15/04/2026

08/04/2026

Latest News